International Baltic Conference on Healthy Longevity 2025 Preliminary Program
International advancement of research, development, education and policy for healthy longevity
Developing the OECD framework for healthy ageing
The national program for preventing cardiovascular diseases and diabetes
Optimization of longevity therapeutics and development of new medical devices and pharmaceutical dosage systems
Pioneering Longevity Medicine: AI, Clinical Implementation & the Future
Hormone replacement therapy in postmenopausal women – is it a Longevity treatment?
Dr. Marta Kobzevaite, Longevity Alliance Baltic (LAB); Yuri Ostrinski, Riga Stradins University; Prof. Dr. Valdis Pirags, University of Latvia
Amit Goldman, EMBA, Longevity Education Hub; Prof. Evelyne Bischof, Sheba Longevity Center; Dr. Svjatoslavs Kistkins, Pauls Stradiņš Clinical University Hospital; Dr. Silvija Valdonė Alšauskė
New physiological models of aging and longevity. Or what terminal illness can teach about longevity?
SGLT2 Inhibitors and GLP-1 Agonists – Modern Gerotherapeutics: A United Strategy or Separate Pathways?
The Role of Retrotransposable Elements (Retrobiome) in Aging and Age-Related Diseases
Chronic Inflammation as the Hallmark of Aging: Association Between Elevated suPAR Biomarker and Accelerated Aging
Microbiome: A pharmaceutical approach to longevity and disease prevention
Insights into metabolic and endocrine regulation in longevity and chronobiology
Physical exercise as a targeted healthy longevity intervention